The number of people with liver cancer will nearly double worldwide by 2050 unless more is done to address preventable causes ...

CONSHOHOCKEN, PA, USA I July 30, 2025 I Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal”) today announced that it has entered into an exclusive ...

A new report in “The Lancet” finds liver cancer cases are preventable, with some steps to abide by. A new analysis of ...

Madrigal Pharmaceuticals said on Wednesday it has entered into a licensing agreement worth up to $2 billion with China's CSPC Pharmaceutical Group to develop an oral GLP-1 drug for a serious form of ...

The researchers found that the aging process causes liver cells called hepatocytes to die through a process called ferroptosis, which depends on iron. This cell death is made worse by metabolic stress ...

Madrigal Pharmaceuticals said on Wednesday it has entered into an up to $2 billion global license agreement with CSPC Pharmaceutical to develop an oral GLP-1 drug for a type of liver disease.

In a majority of cases, liver cancer does not doesn't have to happen if people avoid risk factors, a new global study ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...

As we mark World Hepatitis Day, WHO calls on governments and partners to urgently accelerate efforts to eliminate viral ...

Bausch Health has struck a deal to buy Durect for $63 million upfront, landing a phase 3-ready liver disease candidate that the companies believe has blockbuster potential.

Chronic inflammation can stem from weight, age, stress, pollution, and lifestyle choices. Learn the top contributors and how ...

Experts call for urgent global action on hepatitis, alcohol, and obesity as new data shows that while preventable liver cancer cases are on the rise, the right mix of policy, prevention, and public ...